These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4275737)

  • 1. Distinction of serum inhibitor of activator-induced clot lysis from alpha1-antitrypsin.
    Aoki N; Moroi M
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):567-70. PubMed ID: 4275737
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma inhibitors of the components of the fibrinolytic pathway in man.
    Schreiber AD; Kaplan AP; Austen KF
    J Clin Invest; 1973 Jun; 52(6):1394-401. PubMed ID: 4122174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor of proteinases in cultures of human lung: a new alpha1 antiplasmin/antitrypsin?
    Bernik MB
    Thromb Res; 1977 Dec; 11(6):739-46. PubMed ID: 146276
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolytic inhibitors in human seminal plasma.
    Liedholm P; Astedt B
    Experientia; 1974 Oct; 30(10):1113-4. PubMed ID: 4279828
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum inhibitors in fibrinolysis.
    Gallimore MJ
    Br J Haematol; 1975 Oct; 31(2):217-31. PubMed ID: 53065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on an inhibitor of plasminogen activators in human platelets.
    Murray J; Crawford GP; Ogston D; Douglas AS
    Br J Haematol; 1974 Apr; 26(4):661-8. PubMed ID: 4276857
    [No Abstract]   [Full Text] [Related]  

  • 7. The mechanism of activation of rabbit plasminogen by urokinase. Lack of a preactivation peptide.
    Sodetz JM; Brockway WJ; Mann KG; Castellino FJ
    Biochem Biophys Res Commun; 1974 Sep; 60(2):729-36. PubMed ID: 4278813
    [No Abstract]   [Full Text] [Related]  

  • 8. Purification and partial characterization of pas-positive inclusion bodies from the liver in alpha 1-antitrypsin deficiency.
    Eriksson S; Larsson C
    N Engl J Med; 1975 Jan; 292(4):176-80. PubMed ID: 45843
    [No Abstract]   [Full Text] [Related]  

  • 9. [Purification of soybean trypsin inhibitor by an immunosorption method].
    Fedurkina NV; Mosolov VV
    Prikl Biokhim Mikrobiol; 1984; 20(4):452-7. PubMed ID: 6433341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of plasminogen activator from vascular trees of human cadavers. Its comparison with urokinase.
    Aoki N
    J Biochem; 1974 Apr; 75(4):731-41. PubMed ID: 4847212
    [No Abstract]   [Full Text] [Related]  

  • 11. Trypsin inhibitor from cow colostrum. Isolation, electrophoretic characterization and immunologic properties.
    Piñeiro A; Ortega F; Uriel J
    Biochim Biophys Acta; 1975 Jan; 379(1):201-6. PubMed ID: 803842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies of fibrinolytic inhibitors in vitro.
    Maki M; Beller FK
    Thromb Diath Haemorrh; 1966 Dec; 16(3):668-86. PubMed ID: 4231539
    [No Abstract]   [Full Text] [Related]  

  • 13. Chicken alpha2-proteinase inhibitor: a serum protein homologous with ovoinhibitor of egg white.
    Barrett AJ
    Biochim Biophys Acta; 1974 Nov; 371(1):52-62. PubMed ID: 4214561
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 15. The inhibition of proteinases by human alpha1-antitrypsin.
    Hercz A
    Eur J Biochem; 1974 Nov; 49(1):287-92. PubMed ID: 4282074
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro and in vivo studies with trasylol, an anticoagulant and a fibrinolytic inhibitor.
    Dubber AH; McNicol GP; Uttley D; Douglas AS
    Br J Haematol; 1968 Jan; 14(1):31-49. PubMed ID: 4229180
    [No Abstract]   [Full Text] [Related]  

  • 17. Human pancreatic proteolytic enzymes and protein inhibitors. Isolation and molecular properties.
    Feinstein G; Hofstein R; Koifmann J; Sokolovsky M
    Eur J Biochem; 1974 Apr; 43(3):569-81. PubMed ID: 4208854
    [No Abstract]   [Full Text] [Related]  

  • 18. Purification and properties of normal human alpha 1-antitrypsin.
    Crawford IP
    Arch Biochem Biophys; 1973 May; 156(1):215-22. PubMed ID: 4125886
    [No Abstract]   [Full Text] [Related]  

  • 19. Acid-stable trypsin-plasmin inhibitors formed enzymatically from plasma precursor protein.
    Sumi H; Yoshida E; Hamada H; Mihara H
    Biochim Biophys Acta; 1988 Jul; 966(1):1-11. PubMed ID: 2968815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic capacity in human plasma. I. Measurement of proteolytic activity in the presence of natural inhibitors and study of the inter-individual variations.
    Jacobsen CD
    Scand J Clin Lab Invest; 1968; 21(3):216-26. PubMed ID: 4236912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.